Related by context. All words. (Click for frequent words.) 63 facilitates comparisons 57 nonGAAP 56 non GAAP 55 Comparability 54 meaningful supplemental 53 enhances comparability 53 useful supplemental 52 Adjusted EBITDA 52 Generally Accepted Accounting Principle 51 GAAP 51 netincome 50 comparative 50 pro forma adjusted EBITDA 50 Adjusted Diluted EPS 50 Adjusted Pro Forma 50 adjusted EBITDA 50 adjusted ebitda 50 EBDT 49 Adjusted Earnings 49 Adjusted EPS 49 items affecting comparability 49 Pro forma Adjusted EBITDA 49 pro forma 49 ATCF 49 SFAS #R 48 EBITDA 48 REITs FFO 48 intersegment transactions 48 condensed consolidated 48 adjusted EBITDAR 48 Segment EBITDA 48 Adjusted Basis 48 consolidated OIBDA 48 Non GAAP 48 non gaap 48 Accounting Principles GAAP 47 - -facially insufficient 47 QUALCOMM Strategic Initiatives 47 Adjusted EBITDA excludes 47 Unlevered Cash Flow 47 diluted EPS 47 AFFO 47 SSNOI 47 Consolidated Adjusted EBITDA 47 adopting SFAS #R 47 FFO FFO 47 adjusted unlevered free 47 GAAP Generally Accepted 47 FFOM 47 NOI SS NOI 47 GASB Statement No. 47 Banks.com s 47 FFOPS 46 FFO 46 operatingincome 46 ended December# 46 FAS #R 46 SS NOI 46 FIFO EBITDA 46 No. #R 46 Equinix excludes 46 Core FFO 46 similarly titled captions 46 RAD SVT 46 CGAAP 46 Adjusted EBITDAX 46 accompanying condensed consolidated 46 similarly titled measures 46 adjusted EBITDAS 46 SS NOI helps 46 adopting IFRS 46 Non GAAP Measures 46 Synthetic Fuel segment 46 attached condensed consolidated 45 non recurring 45 depreciation noncash 45 NON GAAP MEASURES 45 adjusted EPS 45 earnings pershare 45 EBITDA adjusted EBITDA 45 FSP #-# 45 invoiced shipments 45 Non GAAP Adjusted EBITDA 45 Tables reconciling 45 REIT taxable 45 Managements Discussion 45 Och Ziff Funds 45 SFAS No.#R 45 LIFO accounting 45 unaudited pro forma 45 pharmacokinetic equivalence 45 NON GAAP 45 Certain reclassifications 45 unaudited condensed 45 adjusted OIBDA margin 45 Distributable Cash 45 accompanying reconciliations 45 ended September# 45 Variable Interest Entities VIEs 44 Adjusted EBITDAS 44 accompanying unaudited consolidated 44 FSP APB #-# 44 intersegment revenues 44 MFFO 44 items impacting comparability 44 infrequently occurring 44 Reclassifications 44 condensed consolidated balance sheets 44 amortization expense 44 Oxy ER 44 SEGMENTED INFORMATION 44 Free Cash Flow 44 excluding QSI 44 FSP EITF #-#-# [002] 44 IFRS changeover 44 Generally Accepted Accounting Principles 44 Adjusted EBIT 44 Distributable Income 44 reclassifications 44 Financial Instruments Disclosures 44 Consolidated EBITDA 44 Pro forma EPS 44 Cautionary Information 44 USGAAP 44 OPEB expense 44 non GAAP Measures 44 standardized distributable cash 44 Fully Diluted Comparable FFO 44 Pro forma 44 comparability purposes 43 WESTWOOD ONE INC. SUPPLEMENTAL 43 Certain comparative 43 EBITDAX 43 normalized FFO guidance 43 asset valuation allowance 43 Income Loss 43 EnPro consolidated 43 Adjusted OIBA 43 Non GAAP Disclosures 43 FINANCIAL MEASURES 43 Adjusted diluted 43 NAREIT definition 43 Fabricated Products segment 43 unaudited consolidated balance sheets 43 Pro Forma Adjusted EBITDA 43 Operational EBITDA 43 covenant calculations 43 intersegment eliminations 43 normalized FFO 43 Adjusted FFO 43 corresponding reconciliations 43 financialstatements 43 EBITDA Adjusted EBITDA 43 reportable segments 43 Consolidated EBITDAR 43 condensed consolidated statements 43 FINANCIAL CONDITION AND 43 Earnings Per Share 43 income allocable 43 Measures Reconciliation 43 reportable segment 43 IFRSs 43 reconciles GAAP 43 Equity Investees 43 reconciles Adjusted EBITDA 43 SFAS# R 43 Significant Items 43 intercompany transactions 43 comparable 43 Non GAAP diluted 43 excluding goodwill impairment 43 Adjusted FIFO EBITDA 43 retroactive restatement 43 Adjusted Gross Margin 43 profitsharing 43 Adjusted EBITDAR 43 proforma 43 Consolidated Cash Flow 43 FASB ASC 43 From Operations AFFO 43 similarly captioned 42 Canadian Generally Accepted 42 Standardized Distributable Cash 42 Recurring FFO 42 FFO Measures 42 financialperformance 42 fiscal# 42 APB# 42 continuingoperations 42 distort comparability 42 Lowest relative 42 Non GAAP EPS 42 stock basedcompensation 42 nonrecurring items 42 Modified EBITDA 42 depreciation amortization accretion 42 Non GAAP Reconciliations 42 Consolidated Cash Flows 42 NON GAAP FINANCIAL MEASURES 42 * Reclassified 42 adopted SFAS #R 42 Comparable Basis 42 IAS IFRS 42 Munghana Lonene Listenership 42 EBIAT 42 Adjusted EBITDA Margin 42 Adjusted Net 42 XBRL formatted 42 TEP UNS Gas 42 Qualcomm Strategic Initiatives 42 efficiency ratio teb 42 Non GAAP Reconciliation 42 retrospectively adjusted 42 Adjusted Gross Profit 42 Non GAAP Measure 42 EDITDA 42 Distributable Cash Flow 42 affecting comparability 42 #.#-#.# bln usd [004] 42 internally evaluates 42 unaudited consolidated interim 42 EBITDAC 42 adjusted distributable cash 42 #.# perdiluted 42 calculating distributable cash 42 Position APB #-# 42 Adjusted Earnings Per 42 Non GAAP adjusted EBITDA 42 CFFO 42 SFAS No. 42 Items affecting comparability 42 Summary Compensation 42 GAAP Measures 41 Non GAAP Adjusted 41 NON RECURRING ITEMS 41 Normalized EBITDA 41 -Amos Harel Haaretz Correspondent 41 -juking stiff 41 CCPU 41 unaudited consolidated financial 41 calculating SS NOI 41 condensed consolidated financial 41 Adjusted EBTIDA 41 Balance Sheet Cash Flow 41 nonrecurring 41 GAAP EPS 41 LTM Adjusted EBITDA 41 Pro forma EBITDA 41 Non IFRS 41 Internally DTE Energy 41 German Purity Laws 41 IFRS 41 normalized EBITDA 41 unaudited condensed consolidated 41 Distribution Coverage Ratio 41 consolidated condensed 41 ROAE 41 noncash depreciation 41 Recent Accounting Pronouncements 41 Concur excludes 41 Constant Currency 41 GAAPs 41 FAS# R 41 comparable GAAP 41 SEC Regulation FD 41 Fully Taxed EPS 41 interim condensed consolidated 41 generic Depakote 41 Adjusted EBIDTA 41 MoxDuo TM IR 41 AOCF 41 Pro Forma Combined 41 Diluted EPS 41 LIFO inventory 41 Net Loss 41 DNOI 41 Adjusted Operating Margin 41 IAROC 41 #.#per diluted 41 diluted share 41 Superior TeleCom 41 LIFO adjustments 41 Income Statement 41 carryforwards 41 EBDDT 41 prioryear 41 Pro Forma Results 41 Levered Free Cash Flow 41 Comparable bakery cafe 41 Including discontinued operations 41 normalized EPS 41 EITF #-# [001] 41 EPADS 41 Non GAAP net 41 NMHG Retail 41 interpretability 41 Comparable EBITDA 41 subjective determinations 41 NewHeights Software Corporation 41 adjusted EBIT 40 All lease pmts 40 footnotes thereto 40 Crisa acquisition 40 applies prospectively 40 EPS 40 Pro Forma EBITDA 40 valuation allowance 40 remeasurements 40 compensation expense 40 LIFO inventory valuation 40 retrospectively restated 40 andoperating 40 Adjusted Distributable Cash 40 Regulation SK 40 Adjusted EBITA 40 Capital Disclosures 40 Gaap 40 FIFO inventory 40 FirstPass Silicon TM 40 applied prospectively 40 postretirement benefit plans 40 Pro Forma Non GAAP 40 NOL utilization 40 consolidated balance sheets 40 acquired Brooks Eckerd 40 adopting SFAS 40 Descriptive statistics 40 No. #R SFAS 40 Fourth Quarter Results 40 GUIDANCE AND 40 excludes depreciation 40 retroactively restated 40 Audited Consolidated 40 Half Yearly Financial 40 -Elie Nadelman 40 Exceptional Items 40 accretion dilution 40 OSI Geospatial Inc 40 EquiTrend ® 40 dilutive antidilutive effects 40 LIFO inventory accounting 40 EBITDAS 40 calculating FFO 40 pro forma condensed consolidated 40 believes EBDDT 40 condensed consolidated interim 40 invoiced shipment 40 SEGMENT REPORTING 40 Diluted earnings 40 GAAP Adj 40 Net Income 40 EBITANCE 40 contingently issuable shares 40 distributable cash flow 40 Unleveraged IRR 40 Statement #R 40 Q#/FY# 40 AND SUBSIDIARIES SEGMENT REPORTING 40 Supplies Distributors 40 Normalized EPS 40 AcG 40 IFRS IFRS 40 = Adjusted [004] 40 FSP FAS #-# 40 SFAS No.# 40 Adjusted Non GAAP 40 incur indebtedness 40 Segmental analysis 40 Regulation G 40 tables summarize 40 Pharmacokinetic parameters 40 similarly titled 40 AND PRO FORMA 40 Taxable equivalent 40 realizability 40 QUALCOMM pro forma 40 LBITDA 40 reconciliations 40 captioned Adjusted EBITDA 40 CICA Section 40 Summarized below 40 depreciation accretion 40 Cash Flow Margin 40 Vaxfectin R 40 Appendix I. 40 Pro Forma EPS 40 Note Certain reclassifications 40 contingently convertible securities 40 ANOI 40 GAAP NON GAAP 40 Pro forma diluted 40 visit www.bjsinvestor.com 40 nonroutine income 40 comparisons 39 reconciles EBITDA 39 Non GAAP Financial 39 g Represents 39 CEDC discusses 39 impacting comparability 39 Cash Flow Statement 39 Pro forma adjustments 39 includedin 39 FAD variously defined 39 Position SOP #-# 39 Comparative Figures 39 presents ROAE 39 LOSS AND ADJUSTED 39 Reported ments 39 FRSSE 39 Non GAAP Measurements 39 USD#.#m USD#.# per [002] 39 Condensed Consolidated Income 39 PreGen Plus 39 understandability 39 SFAS 39 Derivative Liabilities 39 metric signaling 39 retailing vending 39 Accounting Principles 39 SYNERGY Stent 39 Supplemental Schedules 39 EITF #-# [002] 39 QSI segment 39 Norsat audited consolidated 39 interim unaudited consolidated 39 DEPS 39 FINANCIAL INFORMATION 39 Arana Therapeutics Limited 39 f Represents 39 Explanatory Note 39 MA PFFS 39 endedDecember 39 Amortization EBITDA 39 AMERISTAR CASINOS INC. AND 39 Diluted 39 Form# K 39 = Non GAAP [014] 39 BUSINESS OUTLOOK 39 adopted SFAS 39 Financial Measures 39 -Kahaani Ghar Ghar Ki 39 Unusual Items section 39 Predecessor Period 39 Successor Period 39 unaudited Consolidated Statement 39 QCR HOLDINGS INC. CONSOLIDATED 39 FRS# 39 OCF margin 39 materiality threshold 39 actualresults 39 Pro Forma Adjusted 39 involve risksand uncertainties 39 Principles GAAP 39 LAE reserves 39 f Reflects 39 VIEs 39 share excluding AOCI 39 excludes amortization 39 hematological parameters 39 risksand uncertainties 39 Supplemental Non GAAP 39 IAS# [002] 39 USD#.#m USD#.# [002] 39 XBRL taxonomy 39 noninterest expense decreased 39 Non GAAP Proforma 39 Based Compensation 39 excluding BIBP 39 ROIC 39 CASM excluding fuel 39 nondeductible expenses 39 economically defeasing 39 visit www.c cor.com 39 bond indentures 39 calculate FFO 39 AIFRS 39 Selected GAAP Measures 39 FASB Statement 39 distributable cash 39 > > > [002] 39 x fluctuating beryllium 39 pro forma EBITDA 39 IPSAS 39 DiaMed acquisition 39 CONSOLIDATED RESULTS 39 Statutory Accounts 39 methodological rigor 39 FFO FAD 39 SEK -#.# [002] 39 un audited 39 toreflect 39 nonoperating items 39 NON GAAP RECONCILIATION 39 covenant ratios 39 theseforward looking 39 Introductory teaser rates 39 per dilutedshare 39 acquisitive peer 39 b Reflects 39 Zhaoyuan Shuangji 39 VETO HB 39 TVAAS 39 Revises Full 39 Earnings Guidance 39 ASC #-# 39 Largo website www.largoresources.com 39 Adjusted DEPS 39 HKAS 39 Excluding goodwill impairment 39 CICA Handbook 39 Annualized ROE 39 inventories revalued 39 profitability 39 OIBDA 39 Segmented Results 39 Continuing Operations 39 acquisitions divestitures joint ventures 39 DAC unlock 39 excluding divestments 39 No. #R Share 39 PRASM 39 Beta coefficient 39 Supplemental Financials 39 Normalized FFO 39 pension curtailment 39 OPERATING RESULTS 39 OIBDAN 38 Handbook Section 38 GSCT program 38 calculating TCE 38 ROAA 38 NOI FFO 38 standard meanings prescribed 38 FY'# [001] 38 Invested Capital ROIC 38 Supplementary Data 38 Appendix 4E 38 cash flows 38 Adjusted EBITDA Adjusted 38 EBITDA margin 38 FASB ASC #-# 38 SEK -#.# -#.# [003] 38 theSecurities 38 credit carryforwards 38 debt extinguishments 38 share assuming dilution 38 Adjusted OIBDA Margin 38 SFAS#R 38 accompanying Management Discussion 38 RECONCILIATIONS Unaudited 38 Annual Audited Consolidated 38 Specialized REITs industry 38 Amending Directive 38 FFO Adjusted FFO 38 NMHG Wholesale 38 Valhi stockholders 38 accounting pronouncements 38 Adjusted Operating 38 EBITDARM 38 Fully diluted earnings 38 Our PMVS 38 http:/www.mpegla.com 38 microcap segment 38 noncash accounting 38 exclude noncash 38 transparency 38 goodwill impairment 38 proportionately consolidated 38 Consolidated OIBDA 38 Restatements 38 Pro forma net 38 segment adjusted OIBDA 38 PRO FORMA 38 Saxo Bank utilizes 38 BIBP 38 FASB #R 38 FREE CASH FLOW 38 GDP deflator broad 38 futureperformance 38 Drivetrain segment 38 FAS CAS pension 38 Relevant Triad Guaranty 38 Wireline segment 38 financialresults 38 Historical Pro Forma 38 EHSK 38 unrealized derivative gains 38 Preliminary Third Quarter 38 LIFO method 38 Subsidiaries Consolidated Condensed 38 Ps.#.# [006] 38 USE OF NON GAAP 38 MANAGEMENT DISCUSSION AND ANALYSIS 38 Not Meaningful 38 EBITDA EBITDAM EBITDAR 38 forward.looking statements 38 OTTI charges 38 Schedule UTP 38 discontinued operations 38 theprior 38 guaranty insurers 38 futureresults 38 adjusted OIBDA 38 Condensed Consolidated Statement 38 LUXOTTICA GROUP CONSOLIDATED FINANCIAL 38 LIFO adjustment 38 securitized Timeshare notes 38 report chartpoppers.com 38 contemporaneous documentation 38 website www.gasb.org 38 Summarized consolidated 38 annualized ROA 38 NOL carryforwards 38 Normalized EBIT 38 Veresen 38 Operating Income 38 Fair Value Measurements 38 Three Months EndedDecember 38 Pro forma adjusted EBITDA 38 CICA Accounting Guideline 38 uncollectible accounts receivable 38 EARNINGS GUIDANCE 38 Diluted EPS attributable 38 goodwill impairment charge 38 AND CASH FLOW 38 Operational Results 38 Coal lignite coal 38 - Adjusted [030] 38 NBCR risks 38 CONSOLIDATED SUMMARY OF OPERATIONS 38 Profit Margin 38 sampling variability 38 TCE ratio 38 SuiteCloud Connect 38 SUPPLEMENTAL DISCLOSURES REGARDING NON 38 Reconciliation Tables 38 accounting principles 38 Items Affecting Comparability 38 Proforma adjustments 38 EITF #-#-# 38 investable indices 38 ROFE 38 Adjusted Diluted Earnings 38 supplement reconciles 38 attached unaudited condensed 38 POLYCOM INC. GAAP 38 adjusted EBITA 38 NuroPro protein biomarkers 38 normalized EBIT 38 excluding nonrecurring 38 adversely affect Waste Connections 38 standardized meanings 38 BioForce Nanosciences actual 38 EBITDAR 38 COMPARATIVE FIGURES Certain 38 Operations FFO 38 DELAWARE WITH 38 adjusted EBITDA adjusted EBITDA 38 Comparable FFO 38 Individual Annuities segment 38 AGY Asia 38 angiographic outcomes 38 AMEX ABL 38 suchforward looking 38 ARPU CPGA 38 WikiWealth.com s 38 FAS# [003] 38 Schedules 2Q 38 Cash Flow Per Share 38 adjusted CFFO 38 EBTIDA 38 economicconditions 38 Asset Impairment Charge 38 Discontinued Operations 38 Financial Ratios 38 HL Display 38 SY Bancorp 38 GRI Guidelines 38 Non GAAP reconciliations 38 - -OfficeMax ImPress R 38 BioSyent Releases 38 endedSeptember 38 Adjusted EBITDA1 38 PDP MLR 38 affecting orBec ® 38 AND NON GAAP 38 calculated identically 38 animal xenograft models 38 IFRS IASB 38 EBIT 38 REAL ESTATE BUSINESS 37 thethird quarter 37 nine monthsended 37 MtM impacts 37 non GAAP1 37 c Relates 37 MacroChem actual 37 PGiSend 37 tables captioned Reconciliation 37 EURO#.# [002] 37 Segment Operating 37 adopting FAS #R 37 Partnered Brands segment 37 Unaudited Third Quarter 37 Asset Retirement Obligations 37 measurable quantifiable 37 inhospital mortality 37 EBITDA Calculation 37 ARCALYST ® 37 visit www.jbhunt.com 37 d Reflects 37 Harland Clarke Holdings 37 Hedging Relationships 37 UNUSUAL ITEMS 37 resultsof 37 substantively enacted 37 withrespect 37 tabular reconciliation 37 Possible Loan Losses 37 Adjusted Ebitda 37 visit www.PNMResources.com 37 CICA Handbook Section 37 FIN #R 37 Biegelsen wrote 37 footnote disclosures 37 RECONCILIATION OF NON GAAP 37 FIFO gross 37 Condensed Statement 37 Form #QSB 37 Adjusted Homebuilding EBITDA 37 compute FFO 37 OPERATIONS TO ADJUSTED 37 Non inferiority 37 JDA SOFTWARE GROUP INC. 37 consolidated 37 expenses totaled Ps 37 Halotron revenues 37 Reiterates Guidance 37 minesite costs 37 Adjusted OIBDA 37 Adjusted OIBDA excludes 37 NeuCo 37 table reconciles 37 NON GAAP FINANCIAL INFORMATION 37 PMPS brand 37 PROPERTY EBITDA 37 Segmented 37 quarter# 37 operating income1 37 SEGMENT RESULTS 37 nonconvertible debt borrowing 37 loss NOL carryforward 37 Interest Taxes Depreciation 37 FINANCIAL STATEMENTS 37 unaudited Consolidated Statements 37 auditor attestation 37 SEK -# 37 without limitation EMRISE 37 Second Quarter Highlights 37 early extinguishments 37 QSI segment certain 37 Unlevered Free Cash Flow 37 EDWARDS LIFESCIENCES CORPORATION 37 option expensing 37 Earnings 37 currentexpectations 37 Rev. Rul 37 IUR 37 Comparable 37 Non GAAP adjustments 37 Fourth Quarter Fiscal 37 Second Quarter Six Months 37 Unaudited Pro Forma 37 valuation allowances 37 incurs amortization 37 shareowner value 37 website www.daveandbusters.com 37 statistically significant correlations 37 rebased amounts 37 OTTI charge 37 amortizable intangible assets 37 Predecessor Successor 37 Accounting Policies 37 ADJUSTED EBITDA 37 processing PGM ounces 37 noncash impairments 37 - SegmentPrincess Dina Mired 37 -Artunduaga 37 unallocated corporate 37 c Calculated 37 intersegment sales 37 Normalised earnings 37 gross margin 37 Segment EBIT 37 Audited Results 37 ninemonths 37 Comparative 37 dacetuzumab collaboration 37 looking statements.These 37 TO PRO FORMA 37 www.pvh.com 37 acquired intangible assets 37 millioncompared 37 #,#,# #,#,# Diluted [003] 37 otherfactors 37 Reaffirms Full 37 Chemicals Segment 37 PWOD 37 No. #R FAS 37 -tiger muskies 37 TEB adjustment 37 FFO allocable 37 defines FFO 37 quarterended 37 website www.jbhunt.com 37 disaggregates 37 substitutability 37 SHKPI 37 SunLink Specialty Pharmacy 37 intercompany eliminations 37 Supplemental Disclosures 37 Consolidated Entity 37 -gangplanks 37 restrictive covenants contained 37 No. EITF #-#-# 37 please visit http:/www.cnepetroleum.com 37 FAS#R 37 ProfitCents 37 Accounting Guideline AcG 37 Fourth Quarter Ended 37 Explanatory notes 37 LSV Employee Group 37 Restated 37 www.nfp.com 37 acquisitions divestitures transfers 37 per share1 37 EBITDAA 37 Cash Flow Swap 37 Timeshare segment 37 Realised Earnings 37 Month Period 37 - Non GAAP [031] 37 tabular 37 OSIs 37 Items impacting comparability 37 unaudited consolidated 37 visit www.parpharm.com 37 Tangible Common Equity 37 TCE RWA ratio 37 intangibles impairment 37 Supplemental Data 37 Operational Metrics 37 DEPS guidance 37 depletion depreciation 37 -FALL CAMP 37 Financial Statements 37 Ps.3 37 explanatory memoranda 37 Consolidated adjusted EBITDA 37 Imputed Revenue 37 subsidiaries visit uns.com 37 integrating ADVO operations 37 Visit www.transre.com 37 PV module efficiencies 37 Unizan merger 37 MEC racetracks 37 SHFAs 37 follows > 37 3Q FY# 37 TO NON GAAP MEASURES 37 adopting FIN 37 UCITS IV Directive 37 END FOOTNOTE 37 excludes unrealized gains 37 Q4 F# 37 GAAP ADJUSTMENTS 37 Cash Flow Available 37 ROCE 37 CONSOLIDATED OPERATING RESULTS 37 GASB Issues 37 GAAP TO ADJUSTED 37 reclassed 37 antidilutive 37 Hototc.com encourages readers 37 Excluding nonrecurring items 37 IORP Directive 37 Netbacks 37 VERISIGN INC. AND SUBSIDIARIES 37 Variable Interest Entities 37 FIFO method 37 ProLogis Kingspark 37 Predecessor 37 thirdquarter 37 convergent validity 37 information visit www.parpharm.com 37 COFI removal 37 FFO + GOS 37 diluted weighted 37 Exposure Draft 37 amortization OIBA 37 PERIOD ENDED 37 unfavorable variances 37 SuperMedia specializes 37 suchstatements 37 Statutory Accounting Principles 37 Summary RECONCILIATION OF 37 Randomized clinical trials 37 nomograms 37 Vocus filings 37 affecting mortality morbidity 37 methodological differences 37 SEK1 #m 37 GC Impsat 37 Distributable Earnings 37 2Q FY# [001] 37 ratios compare favorably 37 SLHCs 37 gp# vaccine 37 SIFT Rules 37 CRITICAL ACCOUNTING ESTIMATES 37 ActivShopper 37 PACCE trial 37 generalizability 37 Based Compensation Expense 37 ADDITIONAL INFORMATION Additional 37 accompanying unaudited condensed 37 Segmented Information 37 Consolidated EBITDA Margin 37 NYSE VNR Vanguard 37 aircraft separation RVSM 37 Successor Predecessor 37 MHPAEA 37 STOCK BASED COMPENSATION EXPENSE 36 Unleveraged FFO 36 units RVUs 36 EARNINGS MEASURES 36 contractual minimums 36 EGI Financial 36 Surface Specialties acquisition 36 DHC consolidated 36 -Unprovoked 36 - Non GAAP [009] 36 reclassification 36 b Excludes 36 Professional Instrumentation 36 Rating Scale IRLS 36 ASC #-#-# 36 Hedging Relationships AcG 36 restatements 36 NeedleTech 36 Rhonda Barnat spokeswoman 36 Interest Coverage Ratio 36 metrics 36 Octreolin 36 Promotions.com subsidiary 36 OPERATIONS INCLUDING 36 Position EITF #-#-# 36 ascompared 36 noninterest expenses 36 pershare 36 forward lookinginformation 36 Invested Capital 36 MMLP Quarterly Report 36 unallocated expenses 36 addback 36 EMEA Subsidiaries 36 loss allocable 36 - Non Shane Germann 36 Property NOI 36 FINANCIAL STATEMENTS FOR 36 table Normalizing Adjustments 36 visit www.easylink.com 36 CARDINAL HEALTH INC. AND 36 Gross Addition CPGA 36 fiscal year# 36 Before Unusual Items 36 PER UNIT 36 GROUP PJC INC. 36 Color Brightness 36 unaudited Amounts 36 uncertaintiesthat 36 MtM gains 36 EBITD 36 Ps.6 36 comparables 36 AMR CORPORATION NON 36 baseline HbA1c 36 noninterest expense totaled 36 NYSE CHT Chunghwa 36 NAREIT FFO 36 rebased OCF growth 36 PremierWest Bancorp Announces 36 Segmental 36 Medicare Advantage MLR 36 Third Quarter Nine Months 36 Projected Release Date 36 Robben blew kisses 36 offiscal 36 Non GAAP Pro Forma